Who
Shintaro Asako
Director
Company insider
Files Form 4 as: Director, Kura Sushi USA; Director, Acucela; Chief Financial Officer, MediciNova.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 12 Dec 2005
- Last trade
- 2 Feb 2026
- Last filed
- 3 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Feb 2026filed 3 Feb 2026 | KRUS Kura Sushi USARestaurants | SEC FORM 4 Code A | —1,047 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | KRUS Kura Sushi USARestaurants | SEC FORM 4 Code A | —1,047 at $0.00 | filing |
| 3 Feb 2025filed 5 Feb 2025 | KRUS Kura Sushi USARestaurants | SEC FORM 4 Code A | —875 at $0.00 | filing |
| 1 Feb 2024filed 5 Feb 2024 | KRUS Kura Sushi USARestaurants | SEC FORM 4 Code A | —509 at $0.00 | filing |
| 1 Feb 2023filed 2 Feb 2023 | KRUS Kura Sushi USARestaurants | SEC FORM 4 Code A | —804 at $0.00 | filing |
| 1 Feb 2022filed 2 Feb 2022 | KRUS Kura Sushi USAoption or derivative · Restaurants | SEC FORM 4 Code A | —1,546 at $0.00 | filing |
| 1 Feb 2021filed 3 Feb 2021 | KRUS Kura Sushi USAoption or derivative · Restaurants | SEC FORM 4 Code A | —3,290 at $0.00 | filing |
| 2 Dec 2019filed 4 Dec 2019 | KRUS Kura Sushi USAoption or derivative · Restaurants | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 2 Dec 2019filed 4 Dec 2019 | KRUS Kura Sushi USAoption or derivative · Restaurants | SEC FORM 4 Code A | —2,082 at $0.00 | filing |
| 12 Jul 2016filed 14 Jul 2016 | Acucelaoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 21 Jan 2016filed 25 Jan 2016 | Acucelaoption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 18 Jan 2016filed 19 Jan 2016 | Acucelaoption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 29 Jan 2010filed 2 Feb 2010 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,700 at $0.00 | filing |
| 30 Jan 2009filed 3 Feb 2009 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 7 Jan 2008filed 9 Jan 2008 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —74,000 at $0.00 | filing |
| 12 Nov 2006filed 14 Nov 2006 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,064 at $0.00 | filing |
| 4 Jan 2006filed 6 Jan 2006 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 12 Dec 2005filed 6 Jan 2006 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 12 Dec 2005filed 6 Jan 2006 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 12 Dec 2005filed 6 Jan 2006 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.